Top Suppliers:I want be here


1644545-52-7

1644545-52-7 structure
1644545-52-7 structure

Name AG881
Synonyms Vorasidenib
Description Vorasidenib is a pan isocitrate dehydrogenase (IDH) inhibitor.
Related Catalog
Target

IDH[1]

In Vitro Vorasidenib has recently entered phase 1 clinical trials in hematologic (NCT02492737) and solid malignancies (NCT02481154) in patients with either an IDH1 or an IDH2 mutation. Preclinical studies have suggested that Vorasidenib fully penetrates the blood-brain barrier and may be a more effective option for patients with IDH1/2 mutated glioma[1].
References

[1]. Fujii T, et al. Targeting isocitrate dehydrogenase (IDH) in cancer. Discov Med. 2016 May;21(117):373-80.

Molecular Formula C14H13ClF6N6
Molecular Weight 414.74
Storage condition -20℃